Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APVO | MRNA | BMY | AMGN | GILD |
| Company | Aptevo Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7100 | 102.79 | 49.00 | 269.84 | 66.93 |
| High | 0.7200 | 105.43 | 49.56 | 273.14 | 67.57 |
| Low | 0.6700 | 99.30 | 48.87 | 269.84 | 66.74 |
| Last | 0.7100 | 104.46 | 49.14 | 271.91 | 66.95 |
| Change | -0.0174 | +3.05 | +0.21 | +2.98 | +0.19 |
| % Change | -2.39% | +3.01% | +0.43% | +1.11% | +0.28% |
| Volume | 169,400 | 3,176,300 | 7,929,500 | 2,165,700 | 5,622,300 |
| 20-Day Average Volume | 526,940 | 3,320,895 | 11,113,590 | 2,239,560 | 6,350,505 |
| Previous Close | 0.7274 | 101.41 | 48.93 | 268.93 | 66.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.5762 | 105.27 | 50.71 | 272.35 | 69.61 |
| 20-Day Raw Stochastic | 0.92% | 39.49% | 22.23% | 40.27% | 13.17% |
| 20-Day Relative Strength | 25.58% | 51.78% | 42.35% | 47.06% | 32.36% |
| Weighted Alpha | -94.54 | -13.38 | -25.43 | +10.54 | -20.99 |
| Today's Opinion | 100% Sell | 72% Buy | 88% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 64% Buy | 24% Sell | 8% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.32% since 04/15/24 | +0.58% since 04/15/24 | +1.30% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 |
| Low | 0.6700 on 04/22/24 | 99.30 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 0.7979 on 04/16/24 | 106.42 on 04/16/24 | 49.56 on 04/22/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 |
| 1-Month | |||||
| %Chg | -84.43% since 03/22/24 | -0.92% since 03/22/24 | -5.37% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 |
| Low | 0.6700 on 04/22/24 | 97.00 on 04/03/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 4.9979 on 03/28/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -89.38% since 01/22/24 | +4.77% since 01/22/24 | -0.87% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 |
| Low | 0.6700 on 04/22/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 10.8000 on 03/07/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | -95.08% since 10/20/23 | +29.93% since 10/20/23 | -12.96% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 |
| Low | 0.6700 on 04/22/24 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 15.3120 on 10/23/23 | 115.97 on 01/08/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 311 | 38,827,864 | 99,169,320 | 144,247,584 | 83,121,344 |
| Shares Outstanding, K | 428 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -17,410,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -5,900,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 4.89 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -22.03 on 11/14/23 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.44 | 14.09 | 9.85 |